CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Astellas Pharma Inc. v. Lupin Ltd.

1:24-cv-00939

Overview

Case Number 1:24-cv-00939
Filing Date 2024-08-13
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Lupin Pharmaceuticals, Inc. Operating Company

Represented By

2 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Megan C. Haney

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, McLaughlin & Hall, P.A., DE

Lupin Ltd. Operating Company

Represented By

7 Attorneys Listed

William R. Zimmerman

Email: bill.zimmerman@knobbe.com

Matthew S. Friedrichs

Email: matthew.friedrichs@knobbe.com

Jared C. Bunker

Email: jared.bunker@knobbe.com

Carol M. Pitzel Cruz

Email: carol.pitzel.cruz@knobbe.com

Andrea L. Cheek

Email: Andrea.Cheek@knobbe.com

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Megan C. Haney

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, McLaughlin & Hall, P.A., DE

Plaintiff

Astellas Pharma Global Development, Inc. Operating Company

Represented By

5 Attorneys Listed

Michael DelRossi

Email: michael.delrossi@kirkland.com

James F. Hurst

Email: james.hurst@kirkland.com

Diva Hollis

Email: diva.hollis@kirkland.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Astellas Ireland Co., Ltd. Operating Company

Represented By

5 Attorneys Listed

Michael DelRossi

Email: michael.delrossi@kirkland.com

James F. Hurst

Email: james.hurst@kirkland.com

Diva Hollis

Email: diva.hollis@kirkland.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Astellas Pharma Inc. Operating Company

Represented By

5 Attorneys Listed

Michael DelRossi

Email: michael.delrossi@kirkland.com

James F. Hurst

Email: james.hurst@kirkland.com

Diva Hollis

Email: diva.hollis@kirkland.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US12059409
Pharmaceutical composition for modified release
Filed: 2024-03-22
Issued: 2024-08-13
Active (17.3 yrs remaining)
Expires: 2044-03-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 1 Claim Construction / Markman Filing 2

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending
Markman Hearing
Entry #— • 2025-05-16
Claim Construction / Markman Filing Pending / Under Review
ORAL ORDER - IT IS HEREBY ORDERED that, by close of business TODAY, the parties are to submit a proposed form of scheduling order without disputes or arguments ...
Entry #33 • 2025-01-28 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME the deadline for the parties to submit revised case schedules to January 24, 2025 - filed by Astellas Pharma Inc., Astellas Ireland C...
Entry #28 • 2025-01-22 Document →

Docket Entries

(62 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Lupin Ltd., Lupin Pharmaceuticals, Inc. ( Filing fee $ 405, receipt number ADEDC-4475042.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit(s) A-J, # 2 Civil Cover Sheet)(cdd) (Entered: 08/14/2024)

Entry #1 • 2024-08-13
1
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Lupin Ltd., Lupin Pharmaceuticals, Inc. ( Filing fee $ 405, receipt number ADEDC-4475042.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit(s) A-J, # 2 Civil Cover Sheet)(cdd) (Entered: 08/14/2024)

Entry #1 • 2024-08-13
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Lupin Ltd., Lupin Pharmaceuticals, Inc. ( Filing fee $ 405, receipt number ADEDC-4475042.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit(s) A-J, # 2 Civil Cover Sheet)(cdd) (Entered: 08/14/2024)

Entry #1 • 2024-08-13
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) (Entered: 08/14/2024)

Entry #2 • 2024-08-13
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,059,409. (cdd) (Entered: 08/14/2024)

Entry #3 • 2024-08-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc